Biao-Hua Wu
Overview
Explore the profile of Biao-Hua Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kong X, Bu G, Chen H, Huang Y, Liu Z, Kang Y, et al.
J Clin Invest
. 2024 Nov;
135(4).
PMID: 39589824
BACKGROUNDEBV is associated with nasopharyngeal carcinoma (NPC), but the existence of a NPC protective antibody against EBV-associated antigens remains unclear.METHODSPatients with NPC and matched controls were identified from prospective cohorts...
2.
Chen W, Yu X, Lu Y, Pfeiffer R, Ling W, Xie S, et al.
J Clin Oncol
. 2024 Oct;
43(1):22-31.
PMID: 39353160
Purpose: Screening for nasopharyngeal carcinoma (NPC) has shown an improvement in early detection and survival rates of NPC in endemic regions. It is critical to evaluate whether NPC screening can...
3.
Prospective assessment of a nasopharyngeal carcinoma risk score in a population undergoing screening
Chen G, Liu Z, Ji M, Pfeiffer R, Huang Q, Lu Y, et al.
Int J Cancer
. 2020 Dec;
148(10):2398-2406.
PMID: 33285002
Despite evidence suggesting the utility of Epstein-Barr virus (EBV) markers to stratify individuals with respect to nasopharyngeal carcinoma (NPC) risk in NPC high-risk regions, no validated NPC risk prediction model...
4.
Liu Z, Ji M, Huang Q, Fang F, Liu Q, Jia W, et al.
Am J Epidemiol
. 2012 Dec;
177(3):242-50.
PMID: 23255783
A nasopharyngeal carcinoma (NPC) mass screening trial using a combination of immunoglobulin A antibodies to Epstein-Barr virus capsid antigen and nuclear antigen-1 by enzyme-linked immunosorbent assay in addition to indirect...